🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Yesterday, the FDA granted accelerated approval to zanubrutinib combined with obinutuzumab for R/R follicular lymphoma after ≥2 lines of therapy, based on an ORR of 69% vs 46% with obinutuzumab alone; the mDoR was NR (69% at 18 months) vs 14.0 months: fda.gov/drugs/resource…

Registration is now open for a big Central Ohio tradition — Pelotonia. Here's some more information on this year's event: spectrumnews1.com/oh/columbus/ne…

New Research: The role of B-1 cells in cancer progression and anti-tumor immunity: In recent years, in addition to the well-established role of T cells in controlling or promoting tumor growth, a new wave of research has demonstrated the… frontiersin.org/articles/10.33… #immunology

Dr. Kman, emergency medicine physician, talks about staying prepared and safe during a tornado warning… and this includes your car! If you get stuck in your car and see a tornado coming, keep your seat belt on and try to tuck your head away from the windows. 🌪️ Stay safe!

Online Now: Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effects dlvr.it/T574ND

In this Trends in Immunology review, Mengdi Guo,Melissa Liu & DavidBrooksLab discuss "Regulation and impact of tumor-specific CD4+ T cells in cancer and immunotherapy" #ASCO24 hubs.li/Q02yvLl80

Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity - a finding likely generalizable to other cancers. science.org/doi/10.1126/sc…

Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors dlvr.it/T9L8n3

This kid throwing out the first pitch is blind but you would never because he threw a perfect pitch

A complete team work. Thanks to National Cancer Institute and all of my trainees, as well as my amazing collaborators, here and outside of Pelotonia Institute for Immuno-Oncology!! The goal of this grant is to advance our anti-GARP Ab to the clinics.

His dream was to become an IronMan, so his brother made his dream come true despite his cerebral palsy

Congratulations to Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at MassGeneral News, for winning the 2024 #NobelPrize in Physiology or Medicine!

Happy Halloween

🚨 Join us at the 6th Annual Pelotonia Institute for Immuno-Oncology (#PIIO) Symposium! 🚨 🗓 Dates: - Poster Reception: Mon, Dec 2, 5PM - 6:30PM - Symposium: Tue, Dec 3, 8AM - 4PM 📍 Location: Vitria on the Square, Columbus, OH 🌟 Theme: "Personalizing the Fight: From

Wake up, Buckeye Nation! It's ti❌e for THE GA❌E! #GoBucks

Delighted to present our work, 'The Role of IDO enzyme in CTLA-4 Expression in Treg Cells,' at the 6th Annual Symposium of Pelotonia Institute for Immuno-Oncology. A fantastic platform to discuss our research!"

Honored to have the opportunity to attend Arlene Sharpe's insightful talk today in the 6th Annual Symposium of Pelotonia Institute for Immuno-Oncology. Her groundbreaking work continues to inspire advancements in immunology and cancer research.

Congratulations to our amazing trainee talk presenters at #PIIO_2024! 🎉 Dr. Jay Mandula (Zihai Li, MD, PhD Lab), Dr. Elizabeth Garfinkle (Mardis Lab, Nationwide Children's Hospital ), Alex Jin (Gang Xin Lab, #MIIProud), & Dr. Saeed Ahmad (Das Lab, Nationwide Children's Hospital ) – your research is inspiring the

Thank you to Ohio State Medical Oncology Pelotonia Institute for Immuno-Oncology researcher, Dr. Ephraim Ansa-Addo, for presenting at today’s #PIIO Research-in-Progress seminar. 🧬 We appreciated his thoughtful discussion on the intricate roles of #Treg_cells in the #TME & how decoding their regulatory mechanisms

#PIIO-1 (Anti-#GARP #CAR_T) is a milestone worth celebrating together. Grateful to the courageous patient and to everyone who made this possible. Here’s to changing lives. Zihai Li, MD, PhD Li Lab, #OSUCCC #CELL_THERAPY_LAB #Gratitude